Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography

The Trial of Oral Valproic Acid for Retinitis Pigmentosa Group

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

IMPORTANCE: New methods are needed to quantify the change in the outer retinal structures in retinitis pigmentosa (RP). OBJECTIVE: To implement an alternate method for tracking ellipsoid zone (EZ) changes in RP by quantifying the EZ area on en face spectral domain-optical coherence tomographic (SD-OCT) images. DESIGN, SETTING, AND PARTICIPANTS: Data for this observational case study were collected at the Department of Ophthalmology, University of California, Los Angeles, from May 1 to July 30, 2015, and included SD-OCT images of a subset of patients from the Trial of Oral Valproic Acid for Retinitis Pigmentosa. To be eligible for the en face OCT subanalysis, the preserved EZ area was required to be limited to the SD-OCT scanning field. Cases in which the EZ band extended to the margins of any B-scan or the most superior or inferior B-scan were excluded. The SD-OCT images of all included cases were imported into the manufacturer's software to generate en face images at the level of the EZ. Two certified SD-OCT graders independently delineated the boundaries of the preserved EZ on the en face images. MAIN OUTCOMESAND MEASURES: Comparisonof the 2masked gradingsof the generated en face images of patients with RP for agreement between the graders and the validity of the method. RESULTS: Of the 43 available patients with volume SD-OCT data, 45 eyes of 24 patients met the eligibility criteria and were included in this subanalysis. Every patient had 2 visits that were 1 year apart, which included a total of 90 en face OCT images that were graded. The mean (SD) absolute difference and percentage difference between the 2 independent graders for each visit were 0.08 (0.10) mm2 and 4.5% (5.9%), respectively. The EZ area determined by the 2 graders showed excellent agreement with an intraclass correlation coefficient of 0.996 (95% CI, 0.995-0.997; P <.001). CONCLUSIONS AND RELEVANCE: Quantification of the preserved EZ area on en face SD-OCT images of patients with RP is a valid and reproducible method. En face SD-OCT quantification may be a useful tool for monitoring the EZ changes of patients with advanced RP and a useful outcome measurement variable in therapeutic trials.

Original languageEnglish (US)
Pages (from-to)628-635
Number of pages8
JournalJAMA Ophthalmology
Volume134
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Retinitis Pigmentosa
Optical Coherence Tomography
Los Angeles
Valproic Acid
Ophthalmology
Observational Studies
Software

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography. / The Trial of Oral Valproic Acid for Retinitis Pigmentosa Group.

In: JAMA Ophthalmology, Vol. 134, No. 6, 01.06.2016, p. 628-635.

Research output: Contribution to journalArticle

The Trial of Oral Valproic Acid for Retinitis Pigmentosa Group. / Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography. In: JAMA Ophthalmology. 2016 ; Vol. 134, No. 6. pp. 628-635.
@article{44b8eb8694fd4795b0524f79a75e35fa,
title = "Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography",
abstract = "IMPORTANCE: New methods are needed to quantify the change in the outer retinal structures in retinitis pigmentosa (RP). OBJECTIVE: To implement an alternate method for tracking ellipsoid zone (EZ) changes in RP by quantifying the EZ area on en face spectral domain-optical coherence tomographic (SD-OCT) images. DESIGN, SETTING, AND PARTICIPANTS: Data for this observational case study were collected at the Department of Ophthalmology, University of California, Los Angeles, from May 1 to July 30, 2015, and included SD-OCT images of a subset of patients from the Trial of Oral Valproic Acid for Retinitis Pigmentosa. To be eligible for the en face OCT subanalysis, the preserved EZ area was required to be limited to the SD-OCT scanning field. Cases in which the EZ band extended to the margins of any B-scan or the most superior or inferior B-scan were excluded. The SD-OCT images of all included cases were imported into the manufacturer's software to generate en face images at the level of the EZ. Two certified SD-OCT graders independently delineated the boundaries of the preserved EZ on the en face images. MAIN OUTCOMESAND MEASURES: Comparisonof the 2masked gradingsof the generated en face images of patients with RP for agreement between the graders and the validity of the method. RESULTS: Of the 43 available patients with volume SD-OCT data, 45 eyes of 24 patients met the eligibility criteria and were included in this subanalysis. Every patient had 2 visits that were 1 year apart, which included a total of 90 en face OCT images that were graded. The mean (SD) absolute difference and percentage difference between the 2 independent graders for each visit were 0.08 (0.10) mm2 and 4.5{\%} (5.9{\%}), respectively. The EZ area determined by the 2 graders showed excellent agreement with an intraclass correlation coefficient of 0.996 (95{\%} CI, 0.995-0.997; P <.001). CONCLUSIONS AND RELEVANCE: Quantification of the preserved EZ area on en face SD-OCT images of patients with RP is a valid and reproducible method. En face SD-OCT quantification may be a useful tool for monitoring the EZ changes of patients with advanced RP and a useful outcome measurement variable in therapeutic trials.",
author = "{The Trial of Oral Valproic Acid for Retinitis Pigmentosa Group} and Hariri, {Amir H.} and Zhang, {Hong Yang} and Alexander Ho and Peter Francis and Weleber, {Richard G.} and Birch, {David G.} and Ferris, {Frederick L.} and Sadda, {Srini Vas R} and Bernstein, {Paul S.} and John Heckenlively and Alessandro Iannaccone and Lam, {Byron L} and Pennesi, {Mark E.} and Judith Chiostri and Erker, {Laura R.} and Wilson, {David J.} and McCormack, {Jennifer B.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1001/jamaophthalmol.2016.0502",
language = "English (US)",
volume = "134",
pages = "628--635",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography

AU - The Trial of Oral Valproic Acid for Retinitis Pigmentosa Group

AU - Hariri, Amir H.

AU - Zhang, Hong Yang

AU - Ho, Alexander

AU - Francis, Peter

AU - Weleber, Richard G.

AU - Birch, David G.

AU - Ferris, Frederick L.

AU - Sadda, Srini Vas R

AU - Bernstein, Paul S.

AU - Heckenlively, John

AU - Iannaccone, Alessandro

AU - Lam, Byron L

AU - Pennesi, Mark E.

AU - Chiostri, Judith

AU - Erker, Laura R.

AU - Wilson, David J.

AU - McCormack, Jennifer B.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - IMPORTANCE: New methods are needed to quantify the change in the outer retinal structures in retinitis pigmentosa (RP). OBJECTIVE: To implement an alternate method for tracking ellipsoid zone (EZ) changes in RP by quantifying the EZ area on en face spectral domain-optical coherence tomographic (SD-OCT) images. DESIGN, SETTING, AND PARTICIPANTS: Data for this observational case study were collected at the Department of Ophthalmology, University of California, Los Angeles, from May 1 to July 30, 2015, and included SD-OCT images of a subset of patients from the Trial of Oral Valproic Acid for Retinitis Pigmentosa. To be eligible for the en face OCT subanalysis, the preserved EZ area was required to be limited to the SD-OCT scanning field. Cases in which the EZ band extended to the margins of any B-scan or the most superior or inferior B-scan were excluded. The SD-OCT images of all included cases were imported into the manufacturer's software to generate en face images at the level of the EZ. Two certified SD-OCT graders independently delineated the boundaries of the preserved EZ on the en face images. MAIN OUTCOMESAND MEASURES: Comparisonof the 2masked gradingsof the generated en face images of patients with RP for agreement between the graders and the validity of the method. RESULTS: Of the 43 available patients with volume SD-OCT data, 45 eyes of 24 patients met the eligibility criteria and were included in this subanalysis. Every patient had 2 visits that were 1 year apart, which included a total of 90 en face OCT images that were graded. The mean (SD) absolute difference and percentage difference between the 2 independent graders for each visit were 0.08 (0.10) mm2 and 4.5% (5.9%), respectively. The EZ area determined by the 2 graders showed excellent agreement with an intraclass correlation coefficient of 0.996 (95% CI, 0.995-0.997; P <.001). CONCLUSIONS AND RELEVANCE: Quantification of the preserved EZ area on en face SD-OCT images of patients with RP is a valid and reproducible method. En face SD-OCT quantification may be a useful tool for monitoring the EZ changes of patients with advanced RP and a useful outcome measurement variable in therapeutic trials.

AB - IMPORTANCE: New methods are needed to quantify the change in the outer retinal structures in retinitis pigmentosa (RP). OBJECTIVE: To implement an alternate method for tracking ellipsoid zone (EZ) changes in RP by quantifying the EZ area on en face spectral domain-optical coherence tomographic (SD-OCT) images. DESIGN, SETTING, AND PARTICIPANTS: Data for this observational case study were collected at the Department of Ophthalmology, University of California, Los Angeles, from May 1 to July 30, 2015, and included SD-OCT images of a subset of patients from the Trial of Oral Valproic Acid for Retinitis Pigmentosa. To be eligible for the en face OCT subanalysis, the preserved EZ area was required to be limited to the SD-OCT scanning field. Cases in which the EZ band extended to the margins of any B-scan or the most superior or inferior B-scan were excluded. The SD-OCT images of all included cases were imported into the manufacturer's software to generate en face images at the level of the EZ. Two certified SD-OCT graders independently delineated the boundaries of the preserved EZ on the en face images. MAIN OUTCOMESAND MEASURES: Comparisonof the 2masked gradingsof the generated en face images of patients with RP for agreement between the graders and the validity of the method. RESULTS: Of the 43 available patients with volume SD-OCT data, 45 eyes of 24 patients met the eligibility criteria and were included in this subanalysis. Every patient had 2 visits that were 1 year apart, which included a total of 90 en face OCT images that were graded. The mean (SD) absolute difference and percentage difference between the 2 independent graders for each visit were 0.08 (0.10) mm2 and 4.5% (5.9%), respectively. The EZ area determined by the 2 graders showed excellent agreement with an intraclass correlation coefficient of 0.996 (95% CI, 0.995-0.997; P <.001). CONCLUSIONS AND RELEVANCE: Quantification of the preserved EZ area on en face SD-OCT images of patients with RP is a valid and reproducible method. En face SD-OCT quantification may be a useful tool for monitoring the EZ changes of patients with advanced RP and a useful outcome measurement variable in therapeutic trials.

UR - http://www.scopus.com/inward/record.url?scp=84973879056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973879056&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2016.0502

DO - 10.1001/jamaophthalmol.2016.0502

M3 - Article

C2 - 27031504

AN - SCOPUS:84973879056

VL - 134

SP - 628

EP - 635

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 6

ER -